 | • レポートコード：QAF27869 • 出版社/出版日：QYResearch / 2021年5月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の放射性医薬品市場について種類別（アクチニウム-225、ルテチウム-177、ラジウム-223、ホルミウム-166、その他）、用途別（腫瘍学、心臓病学、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・放射性医薬品市場の概要 ・世界の主要地域別放射性医薬品市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の放射性医薬品市場規模2016-2021：種類別（アクチニウム-225、ルテチウム-177、ラジウム-223、ホルミウム-166、その他） ・世界の放射性医薬品市場予測2012-2027：種類別（アクチニウム-225、ルテチウム-177、ラジウム-223、ホルミウム-166、その他） ・世界の放射性医薬品市場規模2016-2021：用途別（腫瘍学、心臓病学、その他） ・世界の放射性医薬品市場予測2012-2027：用途別（腫瘍学、心臓病学、その他） ・放射性医薬品のアメリカ市場規模と予測2016-2021 ・放射性医薬品のヨーロッパ市場規模と予測2016-2021 ・放射性医薬品の中国市場規模と予測2016-2021 ・放射性医薬品の日本市場規模と予測2016-2021 ・放射性医薬品の東南アジア市場規模と予測2016-2021 ・放射性医薬品のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Bracco Imaging、Bayer、Mallinckrodt、Nordion、Triad Isotopes、Lantheus、IBA Group、GE Healthcare、China Isotope & Radiation、Jubilant Pharma、Eli Lilly、Advanced Accelerator Applications、SIEMENS、Dongcheng、Navidea） ・放射性医薬品の製造コスト分析 ・販売チャネル、流通業者、顧客 ・放射性医薬品の市場動向・機会・課題 ・調査の結論 |
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
In the next few years, Radiopharmaceuticals industry will maintain increasing at a relatively high growth rate. Investors are still optimistic about this area; the future will still have more new investment enter the field.
The classification of Radiopharmaceuticals includes Diagnostic Radioisotopes, Therapeutic Radioisotopes. The revenue proportion of Diagnostic Radioisotopes in 2016 is about 77%, and the proportion is in decreasing trend from 2012 to 2017. The Therapeutic Radioisotopes is enjoying more and more market share.
Radiopharmaceuticals are widely used in Oncology, Cardiology and Other disease diagnosis and treatment. The most of radiopharmaceuticals is used in Oncology, and the sales proportion in 2016 is about 60%.
Market Analysis and Insights: Global Radiopharmaceutical Market
The global Radiopharmaceutical market was valued at US$ 6964.1 in 2020 and will reach US$ 11420 million by the end of 2027, growing at a CAGR of 8.6% during 2022-2027.
Global Radiopharmaceutical Scope and Market Size
The global Radiopharmaceutical market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Radiopharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other
Segment by Application
Oncology
Cardiology
Other
The Radiopharmaceutical market is analysed and market size information is provided by regions (countries). Segment by Application, the Radiopharmaceutical market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
1 Radiopharmaceutical Market Overview
1.1 Radiopharmaceutical Product Scope
1.2 Radiopharmaceutical Segment by Type
1.2.1 Global Radiopharmaceutical Sales by Type (2016 & 2021 & 2027)
1.2.2 Actinium-225
1.2.3 Lutetium-177
1.2.4 Radium-223
1.2.5 Holmium-166
1.2.6 Other
1.3 Radiopharmaceutical Segment by Application
1.3.1 Global Radiopharmaceutical Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Radiopharmaceutical Market Estimates and Forecasts (2016-2027)
1.4.1 Global Radiopharmaceutical Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Radiopharmaceutical Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Radiopharmaceutical Price Trends (2016-2027)
2 Radiopharmaceutical Estimates and Forecasts by Region
2.1 Global Radiopharmaceutical Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Radiopharmaceutical Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Radiopharmaceutical Sales Market Share by Region (2016-2021)
2.2.2 Global Radiopharmaceutical Revenue Market Share by Region (2016-2021)
2.3 Global Radiopharmaceutical Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Radiopharmaceutical Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Radiopharmaceutical Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Radiopharmaceutical Estimates and Projections (2016-2027)
2.4.2 Europe Radiopharmaceutical Estimates and Projections (2016-2027)
2.4.3 China Radiopharmaceutical Estimates and Projections (2016-2027)
2.4.4 Japan Radiopharmaceutical Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Radiopharmaceutical Estimates and Projections (2016-2027)
2.4.6 India Radiopharmaceutical Estimates and Projections (2016-2027)
3 Global Radiopharmaceutical Competition Landscape by Players
3.1 Global Top Radiopharmaceutical Players by Sales (2016-2021)
3.2 Global Top Radiopharmaceutical Players by Revenue (2016-2021)
3.3 Global Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radiopharmaceutical as of 2020)
3.4 Global Radiopharmaceutical Average Price by Company (2016-2021)
3.5 Manufacturers Radiopharmaceutical Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Radiopharmaceutical Market Size by Type
4.1 Global Radiopharmaceutical Historic Market Review by Type (2016-2021)
4.1.1 Global Radiopharmaceutical Sales Market Share by Type (2016-2021)
4.1.2 Global Radiopharmaceutical Revenue Market Share by Type (2016-2021)
4.1.3 Global Radiopharmaceutical Price by Type (2016-2021)
4.2 Global Radiopharmaceutical Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Radiopharmaceutical Sales Forecast by Type (2022-2027)
4.2.2 Global Radiopharmaceutical Revenue Forecast by Type (2022-2027)
4.2.3 Global Radiopharmaceutical Price Forecast by Type (2022-2027)
5 Global Radiopharmaceutical Market Size by Application
5.1 Global Radiopharmaceutical Historic Market Review by Application (2016-2021)
5.1.1 Global Radiopharmaceutical Sales Market Share by Application (2016-2021)
5.1.2 Global Radiopharmaceutical Revenue Market Share by Application (2016-2021)
5.1.3 Global Radiopharmaceutical Price by Application (2016-2021)
5.2 Global Radiopharmaceutical Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Radiopharmaceutical Sales Forecast by Application (2022-2027)
5.2.2 Global Radiopharmaceutical Revenue Forecast by Application (2022-2027)
5.2.3 Global Radiopharmaceutical Price Forecast by Application (2022-2027)
6 North America Radiopharmaceutical Market Facts & Figures
6.1 North America Radiopharmaceutical Sales by Company
6.1.1 North America Radiopharmaceutical Sales by Company (2016-2021)
6.1.2 North America Radiopharmaceutical Revenue by Company (2016-2021)
6.2 North America Radiopharmaceutical Sales Breakdown by Type
6.2.1 North America Radiopharmaceutical Sales Breakdown by Type (2016-2021)
6.2.2 North America Radiopharmaceutical Sales Breakdown by Type (2022-2027)
6.3 North America Radiopharmaceutical Sales Breakdown by Application
6.3.1 North America Radiopharmaceutical Sales Breakdown by Application (2016-2021)
6.3.2 North America Radiopharmaceutical Sales Breakdown by Application (2022-2027)
7 Europe Radiopharmaceutical Market Facts & Figures
7.1 Europe Radiopharmaceutical Sales by Company
7.1.1 Europe Radiopharmaceutical Sales by Company (2016-2021)
7.1.2 Europe Radiopharmaceutical Revenue by Company (2016-2021)
7.2 Europe Radiopharmaceutical Sales Breakdown by Type
7.2.1 Europe Radiopharmaceutical Sales Breakdown by Type (2016-2021)
7.2.2 Europe Radiopharmaceutical Sales Breakdown by Type (2022-2027)
7.3 Europe Radiopharmaceutical Sales Breakdown by Application
7.3.1 Europe 143 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 143 Sales Breakdown by Application (2022-2027)
8 China Radiopharmaceutical Market Facts & Figures
8.1 China Radiopharmaceutical Sales by Company
8.1.1 China Radiopharmaceutical Sales by Company (2016-2021)
8.1.2 China Radiopharmaceutical Revenue by Company (2016-2021)
8.2 China Radiopharmaceutical Sales Breakdown by Type
8.2.1 China Radiopharmaceutical Sales Breakdown by Type (2016-2021)
8.2.2 China Radiopharmaceutical Sales Breakdown by Type (2022-2027)
8.3 China Radiopharmaceutical Sales Breakdown by Application
8.3.1 China 314 Sales Breakdown by Application (2016-2021)
8.3.2 China 314 Sales Breakdown by Application (2022-2027)
9 Japan Radiopharmaceutical Market Facts & Figures
9.1 Japan Radiopharmaceutical Sales by Company
9.1.1 Japan Radiopharmaceutical Sales by Company (2016-2021)
9.1.2 Japan Radiopharmaceutical Revenue by Company (2016-2021)
9.2 Japan Radiopharmaceutical Sales Breakdown by Type
9.2.1 Japan Radiopharmaceutical Sales Breakdown by Type (2016-2021)
9.2.2 Japan Radiopharmaceutical Sales Breakdown by Type (2022-2027)
9.3 Japan Radiopharmaceutical Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Radiopharmaceutical Market Facts & Figures
10.1 Southeast Asia Radiopharmaceutical Sales by Company
10.1.1 Southeast Asia Radiopharmaceutical Sales by Company (2016-2021)
10.1.2 Southeast Asia Radiopharmaceutical Revenue by Company (2016-2021)
10.2 Southeast Asia Radiopharmaceutical Sales Breakdown by Type
10.2.1 Southeast Asia Radiopharmaceutical Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Radiopharmaceutical Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Radiopharmaceutical Sales Breakdown by Application
10.3.1 Southeast Asia M Doses Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Doses Sales Breakdown by Application (2022-2027)
11 India Radiopharmaceutical Market Facts & Figures
11.1 India Radiopharmaceutical Sales by Company
11.1.1 India Radiopharmaceutical Sales by Company (2016-2021)
11.1.2 India Radiopharmaceutical Revenue by Company (2016-2021)
11.2 India Radiopharmaceutical Sales Breakdown by Type
11.2.1 India Radiopharmaceutical Sales Breakdown by Type (2016-2021)
11.2.2 India Radiopharmaceutical Sales Breakdown by Type (2022-2027)
11.3 India Radiopharmaceutical Sales Breakdown by Application
11.3.1 India Radiopharmaceutical Sales Breakdown by Application (2016-2021)
11.3.2 India Radiopharmaceutical Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Radiopharmaceutical Business
12.1 Bracco Imaging
12.1.1 Bracco Imaging Corporation Information
12.1.2 Bracco Imaging Business Overview
12.1.3 Bracco Imaging Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bracco Imaging Radiopharmaceutical Products Offered
12.1.5 Bracco Imaging Recent Development
12.2 Bayer
12.2.1 Bayer Corporation Information
12.2.2 Bayer Business Overview
12.2.3 Bayer Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bayer Radiopharmaceutical Products Offered
12.2.5 Bayer Recent Development
12.3 Mallinckrodt
12.3.1 Mallinckrodt Corporation Information
12.3.2 Mallinckrodt Business Overview
12.3.3 Mallinckrodt Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Mallinckrodt Radiopharmaceutical Products Offered
12.3.5 Mallinckrodt Recent Development
12.4 Nordion
12.4.1 Nordion Corporation Information
12.4.2 Nordion Business Overview
12.4.3 Nordion Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Nordion Radiopharmaceutical Products Offered
12.4.5 Nordion Recent Development
12.5 Triad Isotopes
12.5.1 Triad Isotopes Corporation Information
12.5.2 Triad Isotopes Business Overview
12.5.3 Triad Isotopes Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Triad Isotopes Radiopharmaceutical Products Offered
12.5.5 Triad Isotopes Recent Development
12.6 Lantheus
12.6.1 Lantheus Corporation Information
12.6.2 Lantheus Business Overview
12.6.3 Lantheus Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Lantheus Radiopharmaceutical Products Offered
12.6.5 Lantheus Recent Development
12.7 IBA Group
12.7.1 IBA Group Corporation Information
12.7.2 IBA Group Business Overview
12.7.3 IBA Group Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.7.4 IBA Group Radiopharmaceutical Products Offered
12.7.5 IBA Group Recent Development
12.8 GE Healthcare
12.8.1 GE Healthcare Corporation Information
12.8.2 GE Healthcare Business Overview
12.8.3 GE Healthcare Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.8.4 GE Healthcare Radiopharmaceutical Products Offered
12.8.5 GE Healthcare Recent Development
12.9 China Isotope & Radiation
12.9.1 China Isotope & Radiation Corporation Information
12.9.2 China Isotope & Radiation Business Overview
12.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.9.4 China Isotope & Radiation Radiopharmaceutical Products Offered
12.9.5 China Isotope & Radiation Recent Development
12.10 Jubilant Pharma
12.10.1 Jubilant Pharma Corporation Information
12.10.2 Jubilant Pharma Business Overview
12.10.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Jubilant Pharma Radiopharmaceutical Products Offered
12.10.5 Jubilant Pharma Recent Development
12.11 Eli Lilly
12.11.1 Eli Lilly Corporation Information
12.11.2 Eli Lilly Business Overview
12.11.3 Eli Lilly Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Eli Lilly Radiopharmaceutical Products Offered
12.11.5 Eli Lilly Recent Development
12.12 Advanced Accelerator Applications
12.12.1 Advanced Accelerator Applications Corporation Information
12.12.2 Advanced Accelerator Applications Business Overview
12.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Advanced Accelerator Applications Radiopharmaceutical Products Offered
12.12.5 Advanced Accelerator Applications Recent Development
12.13 SIEMENS
12.13.1 SIEMENS Corporation Information
12.13.2 SIEMENS Business Overview
12.13.3 SIEMENS Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.13.4 SIEMENS Radiopharmaceutical Products Offered
12.13.5 SIEMENS Recent Development
12.14 Dongcheng
12.14.1 Dongcheng Corporation Information
12.14.2 Dongcheng Business Overview
12.14.3 Dongcheng Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Dongcheng Radiopharmaceutical Products Offered
12.14.5 Dongcheng Recent Development
12.15 Navidea
12.15.1 Navidea Corporation Information
12.15.2 Navidea Business Overview
12.15.3 Navidea Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Navidea Radiopharmaceutical Products Offered
12.15.5 Navidea Recent Development
13 Radiopharmaceutical Manufacturing Cost Analysis
13.1 Radiopharmaceutical Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Radiopharmaceutical
13.4 Radiopharmaceutical Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Radiopharmaceutical Distributors List
14.3 Radiopharmaceutical Customers
15 Market Dynamics
15.1 Radiopharmaceutical Market Trends
15.2 Radiopharmaceutical Drivers
15.3 Radiopharmaceutical Market Challenges
15.4 Radiopharmaceutical Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Radiopharmaceutical Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Radiopharmaceutical Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Radiopharmaceutical Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Radiopharmaceutical Sales (M Doses) by Region (2016-2021)
Table 5. Global Radiopharmaceutical Sales Market Share by Region (2016-2021)
Table 6. Global Radiopharmaceutical Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Radiopharmaceutical Revenue Share by Region (2016-2021)
Table 8. Global Radiopharmaceutical Sales (M Doses) Forecast by Region (2022-2027)
Table 9. Global Radiopharmaceutical Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Radiopharmaceutical Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Radiopharmaceutical Revenue Share Forecast by Region (2022-2027)
Table 12. Global Radiopharmaceutical Sales (M Doses) of Key Companies (2016-2021)
Table 13. Global Radiopharmaceutical Sales Share by Company (2016-2021)
Table 14. Global Radiopharmaceutical Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Radiopharmaceutical Revenue Share by Company (2016-2021)
Table 16. Global Radiopharmaceutical by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radiopharmaceutical as of 2020)
Table 17. Global Radiopharmaceutical Average Price (USD/Dose) of Key Company (2016-2021)
Table 18. Manufacturers Radiopharmaceutical Manufacturing Sites and Area Served
Table 19. Manufacturers Radiopharmaceutical Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Radiopharmaceutical Sales (M Doses) by Type (2016-2021)
Table 22. Global Radiopharmaceutical Sales Share by Type (2016-2021)
Table 23. Global Radiopharmaceutical Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Radiopharmaceutical Price (USD/Dose) by Type (2016-2021)
Table 25. Global Radiopharmaceutical Sales Share by Type (2022-2027)
Table 26. Global Radiopharmaceutical Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Radiopharmaceutical Revenue Share by Type (2022-2027)
Table 28. Global Radiopharmaceutical Price (USD/Dose) by Type (2022-2027)
Table 29. Global Radiopharmaceutical Sales (M Doses) by Application (2016-2021)
Table 30. Global Radiopharmaceutical Sales Share by Application (2016-2021)
Table 31. Global Radiopharmaceutical Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Radiopharmaceutical Price (USD/Dose) by Application (2016-2021)
Table 33. Global Radiopharmaceutical Sales (M Doses) by Application (2022-2027)
Table 34. Global Radiopharmaceutical Sales Share by Application (2022-2027)
Table 35. Global Radiopharmaceutical Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Radiopharmaceutical Revenue Share by Application (2022-2027)
Table 37. Global Radiopharmaceutical Price (USD/Dose) by Application (2022-2027)
Table 38. North America Radiopharmaceutical Sales (M Doses) by Company (2016-2021)
Table 39. North America Radiopharmaceutical Sales Market Share by Company (2016-2021)
Table 40. North America Radiopharmaceutical Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Radiopharmaceutical Revenue Market Share by Company (2016-2021)
Table 42. North America Radiopharmaceutical Sales by Type (2016-2021) & (M Doses)
Table 43. North America Radiopharmaceutical Sales Market Share by Type (2016-2021)
Table 44. North America Radiopharmaceutical Sales by Type (2022-2027) & (M Doses)
Table 45. North America Radiopharmaceutical Sales Market Share by Type (2022-2027)
Table 46. North America Radiopharmaceutical Sales by Application (2016-2021) & (M Doses)
Table 47. North America Radiopharmaceutical Sales Market Share by Application (2016-2021)
Table 48. North America Radiopharmaceutical Sales by Application (2022-2027) & (M Doses)
Table 49. North America Radiopharmaceutical Sales Market Share by Application (2022-2027)
Table 50. Europe Radiopharmaceutical Sales (M Doses) by Company (2016-2021)
Table 51. Europe Radiopharmaceutical Sales Market Share by Company (2016-2021)
Table 52. Europe Radiopharmaceutical Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Radiopharmaceutical Revenue Market Share by Company (2016-2021)
Table 54. Europe Radiopharmaceutical Sales by Type (2016-2021) & (M Doses)
Table 55. Europe Radiopharmaceutical Sales Market Share by Type (2016-2021)
Table 56. Europe Radiopharmaceutical Sales by Type (2022-2027) & (M Doses)
Table 57. Europe Radiopharmaceutical Sales Market Share by Type (2022-2027)
Table 58. Europe Radiopharmaceutical Sales by Application (2016-2021) & (M Doses)
Table 59. Europe Radiopharmaceutical Sales Market Share by Application (2016-2021)
Table 60. Europe Radiopharmaceutical Sales by Application (2022-2027) & (M Doses)
Table 61. Europe Radiopharmaceutical Sales Market Share by Application (2022-2027)
Table 62. China Radiopharmaceutical Sales (M Doses) by Company (2016-2021)
Table 63. China Radiopharmaceutical Sales Market Share by Company (2016-2021)
Table 64. China Radiopharmaceutical Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Radiopharmaceutical Revenue Market Share by Company (2016-2021)
Table 66. China Radiopharmaceutical Sales by Type (2016-2021) & (M Doses)
Table 67. China Radiopharmaceutical Sales Market Share by Type (2016-2021)
Table 68. China Radiopharmaceutical Sales by Type (2022-2027) & (M Doses)
Table 69. China Radiopharmaceutical Sales Market Share by Type (2022-2027)
Table 70. China Radiopharmaceutical Sales by Application (2016-2021) & (M Doses)
Table 71. China Radiopharmaceutical Sales Market Share by Application (2016-2021)
Table 72. China Radiopharmaceutical Sales by Application (2022-2027) & (M Doses)
Table 73. China Radiopharmaceutical Sales Market Share by Application (2022-2027)
Table 74. Japan Radiopharmaceutical Sales (M Doses) by Company (2016-2021)
Table 75. Japan Radiopharmaceutical Sales Market Share by Company (2016-2021)
Table 76. Japan Radiopharmaceutical Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Radiopharmaceutical Revenue Market Share by Company (2016-2021)
Table 78. Japan Radiopharmaceutical Sales by Type (2016-2021) & (M Doses)
Table 79. Japan Radiopharmaceutical Sales Market Share by Type (2016-2021)
Table 80. Japan Radiopharmaceutical Sales by Type (2022-2027) & (M Doses)
Table 81. Japan Radiopharmaceutical Sales Market Share by Type (2022-2027)
Table 82. Japan Radiopharmaceutical Sales by Application (2016-2021) & (M Doses)
Table 83. Japan Radiopharmaceutical Sales Market Share by Application (2016-2021)
Table 84. Japan Radiopharmaceutical Sales by Application (2022-2027) & (M Doses)
Table 85. Japan Radiopharmaceutical Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Radiopharmaceutical Sales (M Doses) by Company (2016-2021)
Table 87. Southeast Asia Radiopharmaceutical Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Radiopharmaceutical Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Radiopharmaceutical Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Radiopharmaceutical Sales by Type (2016-2021) & (M Doses)
Table 91. Southeast Asia Radiopharmaceutical Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Radiopharmaceutical Sales by Type (2022-2027) & (M Doses)
Table 93. Southeast Asia Radiopharmaceutical Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Radiopharmaceutical Sales by Application (2016-2021) & (M Doses)
Table 95. Southeast Asia Radiopharmaceutical Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Radiopharmaceutical Sales by Application (2022-2027) & (M Doses)
Table 97. Southeast Asia Radiopharmaceutical Sales Market Share by Application (2022-2027)
Table 98. India Radiopharmaceutical Sales (M Doses) by Company (2016-2021)
Table 99. India Radiopharmaceutical Sales Market Share by Company (2016-2021)
Table 100. India Radiopharmaceutical Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Radiopharmaceutical Revenue Market Share by Company (2016-2021)
Table 102. India Radiopharmaceutical Sales by Type (2016-2021) & (M Doses)
Table 103. India Radiopharmaceutical Sales Market Share by Type (2016-2021)
Table 104. India Radiopharmaceutical Sales by Type (2022-2027) & (M Doses)
Table 105. India Radiopharmaceutical Sales Market Share by Type (2022-2027)
Table 106. India Radiopharmaceutical Sales by Application (2016-2021) & (M Doses)
Table 107. India Radiopharmaceutical Sales Market Share by Application (2016-2021)
Table 108. India Radiopharmaceutical Sales by Application (2022-2027) & (M Doses)
Table 109. India Radiopharmaceutical Sales Market Share by Application (2022-2027)
Table 110. Bracco Imaging Corporation Information
Table 111. Bracco Imaging Description and Business Overview
Table 112. Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 113. Bracco Imaging Radiopharmaceutical Product
Table 114. Bracco Imaging Recent Development
Table 115. Bayer Corporation Information
Table 116. Bayer Description and Business Overview
Table 117. Bayer Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 118. Bayer Radiopharmaceutical Product
Table 119. Bayer Recent Development
Table 120. Mallinckrodt Corporation Information
Table 121. Mallinckrodt Description and Business Overview
Table 122. Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 123. Mallinckrodt Radiopharmaceutical Product
Table 124. Mallinckrodt Recent Development
Table 125. Nordion Corporation Information
Table 126. Nordion Description and Business Overview
Table 127. Nordion Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 128. Nordion Radiopharmaceutical Product
Table 129. Nordion Recent Development
Table 130. Triad Isotopes Corporation Information
Table 131. Triad Isotopes Description and Business Overview
Table 132. Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 133. Triad Isotopes Radiopharmaceutical Product
Table 134. Triad Isotopes Recent Development
Table 135. Lantheus Corporation Information
Table 136. Lantheus Description and Business Overview
Table 137. Lantheus Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 138. Lantheus Radiopharmaceutical Product
Table 139. Lantheus Recent Development
Table 140. IBA Group Corporation Information
Table 141. IBA Group Description and Business Overview
Table 142. IBA Group Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 143. IBA Group Radiopharmaceutical Product
Table 144. IBA Group Recent Development
Table 145. GE Healthcare Corporation Information
Table 146. GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 147. GE Healthcare Description and Business Overview
Table 148. GE Healthcare Radiopharmaceutical Product
Table 149. GE Healthcare Recent Development
Table 150. China Isotope & Radiation Corporation Information
Table 151. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 152. China Isotope & Radiation Description and Business Overview
Table 153. China Isotope & Radiation Radiopharmaceutical Product
Table 154. China Isotope & Radiation Recent Development
Table 155. Jubilant Pharma Corporation Information
Table 156. Jubilant Pharma Description and Business Overview
Table 157. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 158. Jubilant Pharma Radiopharmaceutical Product
Table 159. Jubilant Pharma Recent Development
Table 160. Eli Lilly Corporation Information
Table 161. Eli Lilly Description and Business Overview
Table 162. Eli Lilly Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 163. Eli Lilly Radiopharmaceutical Product
Table 164. Eli Lilly Recent Development
Table 165. Advanced Accelerator Applications Corporation Information
Table 166. Advanced Accelerator Applications Description and Business Overview
Table 167. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 168. Advanced Accelerator Applications Radiopharmaceutical Product
Table 169. Advanced Accelerator Applications Recent Development
Table 170. SIEMENS Corporation Information
Table 171. SIEMENS Description and Business Overview
Table 172. SIEMENS Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 173. SIEMENS Radiopharmaceutical Product
Table 174. SIEMENS Recent Development
Table 175. Dongcheng Corporation Information
Table 176. Dongcheng Description and Business Overview
Table 177. Dongcheng Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 178. Dongcheng Radiopharmaceutical Product
Table 179. Dongcheng Recent Development
Table 180. Navidea Corporation Information
Table 181. Navidea Description and Business Overview
Table 182. Navidea Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 183. Navidea Radiopharmaceutical Product
Table 184. Navidea Recent Development
Table 185. Production Base and Market Concentration Rate of Raw Material
Table 186. Key Suppliers of Raw Materials
Table 187. Radiopharmaceutical Distributors List
Table 188. Radiopharmaceutical Customers List
Table 189. Radiopharmaceutical Market Trends
Table 190. Radiopharmaceutical Market Drivers
Table 191. Radiopharmaceutical Market Challenges
Table 192. Radiopharmaceutical Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiopharmaceutical Product Picture
Figure 2. Global Radiopharmaceutical Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Radiopharmaceutical Sales Market Share by Application in 2021 & 2027
Figure 6. Oncology Examples
Figure 7. Cardiology Examples
Figure 8. Other Examples
Figure 9. Global Radiopharmaceutical Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Radiopharmaceutical Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Radiopharmaceutical Sales (M Doses) Growth Rate (2016-2027)
Figure 12. Global Radiopharmaceutical Price Trends Growth Rate (2016-2027) (USD/Dose)
Figure 13. Global Radiopharmaceutical Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Radiopharmaceutical Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Radiopharmaceutical Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Radiopharmaceutical Sales (M Doses) Growth Rate (2016-2027)
Figure 17. Europe Radiopharmaceutical Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Radiopharmaceutical Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Radiopharmaceutical Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Radiopharmaceutical Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Radiopharmaceutical Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Radiopharmaceutical Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Radiopharmaceutical Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Radiopharmaceutical Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Radiopharmaceutical Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Radiopharmaceutical Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Radiopharmaceutical Players Market Share by Revenue in Radiopharmaceutical: 2016 & 2020
Figure 28. Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Radiopharmaceutical Revenue Share by Type (2016-2021)
Figure 30. Global Radiopharmaceutical Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Radiopharmaceutical Revenue Share by Application (2016-2021)
Figure 32. Global Radiopharmaceutical Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Radiopharmaceutical Sales Market Share by Type in 2020
Figure 34. North America Radiopharmaceutical Sales Market Share by Application in 2020
Figure 35. Europe Radiopharmaceutical Sales Market Share by Type in 2020
Figure 36. Europe Radiopharmaceutical Sales Market Share by Application in 2020
Figure 37. China Radiopharmaceutical Sales Market Share by Type in 2020
Figure 38. China Radiopharmaceutical Sales Market Share by Application in 2020
Figure 39. Japan Radiopharmaceutical Sales Market Share by Type in 2020
Figure 40. Japan Radiopharmaceutical Sales Market Share by Application in 2020
Figure 41. Southeast Asia Radiopharmaceutical Sales Market Share by Type in 2020
Figure 42. Southeast Asia Radiopharmaceutical Sales Market Share by Application in 2020
Figure 43. India Radiopharmaceutical Sales Market Share by Type in 2020
Figure 44. India Radiopharmaceutical Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Radiopharmaceutical
Figure 47. Manufacturing Process Analysis of Radiopharmaceutical
Figure 48. Radiopharmaceutical Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed